Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome

Trial Profile

Proper Level of Lipid Lowering with Pitavastatin and Ezetimibe in Acute Coronary Syndrome

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Aug 2017

At a glance

  • Drugs Ezetimibe (Primary) ; Pitavastatin (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms HIJ-PROPER
  • Most Recent Events

    • 30 Aug 2017 Results of a subanalysis assessing impact of hs-CRP and estimate glomerular filtration rate on clinical outcomes presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
    • 30 Aug 2017 Results (n=1721) of sub-analysis presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology.
    • 30 Aug 2017 Results of a subanalysis assessing impact of sitosterol level on clinical outcomes presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top